Trademark Overview
On Thursday, June 11, 2026, a trademark application was filed for TREFISOVE with the United States Patent and Trademark Office. The USPTO has given the TREFISOVE trademark a serial number of 99879139. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 11, 2026. This trademark is owned by AstraZeneca AB. The TREFISOVE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes